Telik
id:
telik-269-8642097
title:
Telik
text:
Telik, Inc. was set up in 1988 and was reverse merged into privately held MabVax in May 2014. The major drug of the company was TELINTRA, an investigational agent that was in development for the treatment of myelodysplastic syndrome (MDS) and idiopathic chronic neutropenia.
brand slug:
wiki
category slug:
encyclopedia
description:
original url:
https://en.wikipedia.org/wiki/Telik
date created:
date modified:
2018-10-07T10:14:49Z
main entity:
{"identifier":"Q17146330","url":"https://www.wikidata.org/entity/Q17146330"}
image:
fields total:
13
integrity:
13